INDIVIOR PLC (INDV) Stock Fundamental Analysis
NASDAQ:INDV - Nasdaq - GB00BN4HT335 - Common Stock - Currency: USD
Taking everything into account, INDV scores 4 out of 10 in our fundamental rating. INDV was compared to 197 industry peers in the Pharmaceuticals industry. INDV has only an average score on both its financial health and profitability. INDV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
INDV had negative earnings in the past year.
In the past year INDV had a positive cash flow from operations.
In multiple years INDV reported negative net income over the last 5 years.
In multiple years INDV reported negative operating cash flow during the last 5 years.
1.2 Ratios
INDV has a Return On Assets of -4.00%. This is in the better half of the industry: INDV outperforms 77.16% of its industry peers.
INDV's Return On Invested Capital of 111.88% is amongst the best of the industry. INDV outperforms 99.49% of its industry peers.
INDV had an Average Return On Invested Capital over the past 3 years of 43.06%. This is in line with the industry average of 42.34%.
The 3 year average ROIC (43.06%) for INDV is below the current ROIC(111.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROIC | 111.88% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
1.3 Margins
INDV's Profit Margin has declined in the last couple of years.
The Operating Margin of INDV (25.44%) is better than 90.36% of its industry peers.
In the last couple of years the Operating Margin of INDV has remained more or less at the same level.
INDV has a better Gross Margin (83.98%) than 88.83% of its industry peers.
In the last couple of years the Gross Margin of INDV has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% |
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INDV is creating value.
The number of shares outstanding for INDV has been reduced compared to 1 year ago.
INDV has less shares outstanding than it did 5 years ago.
The debt/assets ratio for INDV is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.77 indicates that INDV is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of INDV (2.77) is better than 74.11% of its industry peers.
The Debt to FCF ratio of INDV is 2.49, which is a good value as it means it would take INDV, 2.49 years of fcf income to pay off all of its debts.
INDV has a Debt to FCF ratio of 2.49. This is amongst the best in the industry. INDV outperforms 92.39% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Altman-Z | 2.77 |
ROIC/WACC10.7
WACC10.46%
2.3 Liquidity
INDV has a Current Ratio of 0.88. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
INDV's Current ratio of 0.88 is on the low side compared to the rest of the industry. INDV is outperformed by 85.28% of its industry peers.
INDV has a Quick Ratio of 0.88. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of INDV (0.72) is worse than 84.77% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
INDV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1736.71%.
The earnings per share for INDV have been decreasing by -55.78% on average. This is quite bad
Looking at the last year, INDV shows a very strong growth in Revenue. The Revenue has grown by 83.27%.
Measured over the past years, INDV shows a quite strong growth in Revenue. The Revenue has been growing by 8.64% on average per year.
EPS 1Y (TTM)-1736.71%
EPS 3Y-77.57%
EPS 5Y-55.78%
EPS Q2Q%10.81%
Revenue 1Y (TTM)83.27%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%-6.34%
3.2 Future
INDV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.66% yearly.
Based on estimates for the next years, INDV will show a small growth in Revenue. The Revenue will grow by 2.59% on average per year.
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.66%
Revenue Next Year-8.41%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.2%
Revenue Next 5Y2.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INDV. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 7.91 indicates a rather cheap valuation of INDV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 89.85% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of INDV to the average of the S&P500 Index (22.20), we can say INDV is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 7.91 |
4.2 Price Multiples
INDV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INDV is cheaper than 97.46% of the companies in the same industry.
INDV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INDV is cheaper than 90.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.4 | ||
| EV/EBITDA | 2.61 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
5. Dividend
5.1 Amount
INDV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:INDV (5/28/2025, 2:06:39 PM)
12.06
+0.24 (+2.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners89.83%
Inst Owner Change18.17%
Ins Owners3.68%
Ins Owner ChangeN/A
Market Cap1.50B
Analysts82.5
Price Target15.4 (27.69%)
Short Float %2.05%
Short Ratio2.12
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.69%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-15.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.95%
Revenue NY rev (3m)-3.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 7.91 | ||
| P/S | 0.73 | ||
| P/FCF | 11.4 | ||
| P/OCF | 9.06 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 2.61 |
EPS(TTM)-0.38
EYN/A
EPS(NY)1.52
Fwd EY12.64%
FCF(TTM)1.06
FCFY8.77%
OCF(TTM)1.33
OCFY11.03%
SpS16.51
BVpS-2.28
TBVpS-2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4% | ||
| ROE | N/A | ||
| ROCE | 141.62% | ||
| ROIC | 111.88% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 25.44% | ||
| PM (TTM) | N/A | ||
| GM | 83.98% | ||
| FCFM | 6.41% |
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score5
Asset Turnover1.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.49 | ||
| Debt/EBITDA | 0.57 | ||
| Cap/Depr | 136% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 2.77 |
F-Score5
WACC10.46%
ROIC/WACC10.7
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1736.71%
EPS 3Y-77.57%
EPS 5Y-55.78%
EPS Q2Q%10.81%
EPS Next Y-20.5%
EPS Next 2Y-3.84%
EPS Next 3Y2.76%
EPS Next 5Y5.66%
Revenue 1Y (TTM)83.27%
Revenue growth 3Y14.52%
Revenue growth 5Y8.64%
Sales Q2Q%-6.34%
Revenue Next Year-8.41%
Revenue Next 2Y-2.87%
Revenue Next 3Y-0.2%
Revenue Next 5Y2.59%
EBIT growth 1Y103.89%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year13.79%
EBIT Next 3Y10.08%
EBIT Next 5Y12.03%
FCF growth 1Y473.91%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y374.29%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%